Dietary Supplements May Hinder Cancer Cells
Some reasons for the blockage of the production of cells were found out to be from a substance that may be produced when one eats broccoli and Brussels sprouts by several researchers at the Ohio State University Cancer Center (OSUCCC) like Arthur G. James and Richard J. Solove Research Institute.
According to the researchers, convincing proof point out that the substance, indole-3-carbinol (I3C), might have anticancer effects and additional health benefits. The results of their study show on how 13C have an effect on cancer cells and normal cells.
The place for scientific research and animal study revealed a link between I3C and a molecule called Cdc25A, which is necessary for cell division and propagation. The study tells that I3C is the reason for the damage of that molecule and thus stops the growth of breast cancer cells.
The assistant professor of pathology at the Ohio State University Medical Center, Xianghong Zou said that Cdc25A is there at extreme high levels in almost half of breast cancer cases and it is connected with a poor forecast.
He noted that molecules also arise at strangely extreme levels in cancers of the breast, prostate, liver, esophagus, endometrium and colon, and in non-Hodgkin lymphoma, and some other diseases like Alzheimer disease.
Zou says that therefore, an amount of anti-Cdc25 agents have been recognized, although they are not successful for preventing or treatment of cancer due to interests regarding their safety.
He added that I3C prominent results on cancer cells and enhanced knowledge of this device may guide to the use of this dietary supplement as a successful and secure plan for treating a different kind of cancer and other human diseases connected with the over expression of Cdc25A.
Zou and his colleagues revealed three breast cancer cell lines to I3C. These studies proved that the substance produces the damage of Cdc25A. The researchers identified an exact location of the molecule that made it sensitive to I3C, telling that if that location is changed (because of gene mutation), I3C will be no longer be a reason for the damage of molecule.
Finally, investigators used the mouse as model in order to examine the efficiency of I3C in breast tumors. It decreased tumor size by up to 65 percent when the substance was given orally to the mice. They also demonstrate that 13C had no distress on breast-cell tumors in which the Cdc25A molecule has a mutation in that key location.
Connect
|
